02014nam a2200361Ia 4500001001200000003000600012005001700018007001400035008004100049040006300090043001200153074001600165086002800181110016800209245020200377260011400579300002700693336002600720337002700746338003100773490002200804500003600826500002500862533008200887650003600969650004001005650004101045650004801086650001601134776023001150776021301380810005901593ocm49896498OCoLC20170418095514.0he bmb024bbca020531s2002    dcu     b    f000 0 eng d  aMNMbengcMNMdOCLCQdFCMBLdOCLCQdOCLCOdOCLCQdGPOdMvI  an-us---  a1033-A (MF)0 aY 4.AP 6/2:S.HRG.107-871 aUnited States.bCongress.bSenate.bCommittee on Appropriations.bSubcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies.10aBlood cancers :bhearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Seventh Congress, first session, special hearing, June 21, 2001, Washington, DC.  aWashington :bU.S. G.P.O. :bFor sale by the Supt. of Docs., U.S. G.P.O. [Congressional Sales Office],c2002.  aiv, 64 pages ;c24 cm.  atextbtxt2rdacontent  amicroformbh2rdamedia  amicrofichebhe2rdacarrier1 aS. hrg. ;v107-87  aShipping list no.: 2002-0276-M.  aCRDP Program record.  aMicrofiche.bWashington, D.C. :cU.S. G.P.O.d2002.e1 microfiche : negative. 0aBloodxDiseaseszUnited States. 0aLeukemiaxTreatmentzUnited States. 0aLymphomasxTreatmentzUnited States. 0aMultiple myelomaxTreatmentzUnited States. 0aStem cells.08iPrint version:aUnited States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies.tBlood cancersw(DLC) 2002410449w(OCoLC)4921573808iOnline version:aUnited States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies.tBlood cancersw(OCoLC)507072001 aUnited States.bCongress.bSenate.tS. hrg. ;v107-87.